BTG3 and adult-onset Still disease: The cumulative retention rate of ANA at 12, 24, 48, and 60 months of follow-up was 74.3%, 62.9%, 49.4%, and 49.4%, respectively (Figure 1A), without any significant differences between sJIA and AOSD patients (p = 0.164) (Figure 1B).